Table 2 Comparison of demographics and clinical characteristics between the pathological myopic (PM) eyes and non-PM eyes. *p < 0.05.
Clinical parameter | PM (n = 25) | Non-PM (n = 11) | p value |
---|---|---|---|
Age, years | 60.5 ± 10.0 | 47.7 ± 17.2 | 0.0440* |
Gender, male/female | 4/21 | 2/9 | 0.8715 |
Refractive error (D) | −13.8 ± 3.5 | −4.97 ± 3.2 | < 0.0001* |
AL (mm) | 29.4 ± 2.0 | 25.4 ± 1.9 | 0.0008* |
Baseline logMAR BCVA | 0.23 ± 0.3 | 0.09 ± 0.3 | 0.0783 |
Final logMAR BCVA | 0.52 ± 0.6 | −0.02 ± 0.2 | 0.0010* |
Baseline PIC lesion numbers | 5.8 ± 5.5 | 11.8 ± 16.4 | 0.9862 |
Change in number of lesions, increase/decrease or unchanged | 16/7 | 0/11 | < 0.0001* |
PIC lesion area % change/year, % | 27.8 ± 38.4 | 13.3 ± 26.9 | 0.2831 |
MNV, yes/no | 20/5 | 7/4 | 0.2963 |
LC, yes/no | 19/2 | 0/11 | < 0.0001* |
PIC lesion with LCs, yes/no | 16/5 | 0/11 | < 0.0001* |
Macular atrophy, yes/no | 12/13 | 1/10 | 0.0252* |
Follow-up (months) | 91.6 ± 58.3 | 75.8 ± 35.9 | 0.6304 |